Sponsor pipeline

Azafaros B.V. clinical trial pipeline

Get alerts when Azafaros B.V.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
2
Phase 3
3

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07082725 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in… Niemann-Pick Type C Disease Recruiting 2026-09-28
NCT07054515 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in… Niemann-Pick Type C Disease Recruiting 2026-09-24
NCT07082543 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in… Gangliosidoses, GM2 Active, Not Recruiting 2026-09-22
Phase 2
NCT07399704 A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With… GM2 Gangliosidosis Active, Not Recruiting 2026-10-13
NCT07715084 Study to Evaluate the Efficacy and Safety of Nizubaglustat (AZ-3102) in Patients With… Gaucher Disease Type 3 Not Yet Recruiting 2026-07-20
Get alerts when Azafaros B.V.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free